scispace - formally typeset
B

Bárbara B. Garrido-Suárez

Researcher at Spanish National Research Council

Publications -  16
Citations -  147

Bárbara B. Garrido-Suárez is an academic researcher from Spanish National Research Council. The author has contributed to research in topics: Neuropathic pain & Hyperalgesia. The author has an hindex of 6, co-authored 12 publications receiving 123 citations.

Papers
More filters
Journal ArticleDOI

A Mangifera indica L. extract could be used to treat neuropathic pain and implication of mangiferin.

TL;DR: Vimang is an aqueous extract of Mangifera indica L. traditionally used in Cuba for its analgesic, anti-inflammatory, antioxidant and immunomodulatory properties, and also for mangiferin, its major component, which has potential utility in the neuropathic pain treatment.
Journal ArticleDOI

Anti-hypernociceptive effect of mangiferin in persistent and neuropathic pain models in rats

TL;DR: It is suggested that MG shows ability to decrease tonic pain in the formalin test and its neuroprotective effect by preventing WD in mononeuropathic rats could be implicated in the mechano-antihypernociceptive long term mechanisms.
Journal ArticleDOI

Pre-emptive anti-hyperalgesic effect of electroacupuncture in carrageenan-induced inflammation: role of nitric oxide.

TL;DR: Data constitute the first report that suggested the participation, at least in part, of the L-arginine-NOS-NO-GMPc pathway activation in anti-hyperalgesic effect of EA in carrageenan-induced inflammation model.
Journal ArticleDOI

Combination of Mangifera indica L. extract supplementation plus methotrexate in rheumatoid arthritis patients: a pilot study.

TL;DR: Treatment's efficacy was demonstrated with ACR criteria and only the patients of MTX‐Vimang group revealed statistically significant improvement in DAS 28 parameters with respect baseline data but no differences were observed between groups.
Journal ArticleDOI

Mangiferin: Possible uses in the prevention and treatment of mixed osteoarthritic pain

TL;DR: Mangiferin (MG) is a glucosylxanthone that is broadly distributed in higher plants, and its potential utility as a multitargeted compound for mixed OA pain, even in the context of multimodal pharmacotherapy is proposed.